Literature DB >> 29394408

Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis.

Žiga Rotar1, Matija Tomšic1,2, Alojzija Hocevar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29394408     DOI: 10.1093/rheumatology/kex507

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

Review 1.  Role of Neutrophils in Systemic Vasculitides.

Authors:  Despina Michailidou; Tomas Mustelin; Christian Lood
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

Review 2.  Biologic Therapies for Giant Cell Arteritis.

Authors:  Robert Harrington; Shamma Ahmad Al Nokhatha; Richard Conway
Journal:  Biologics       Date:  2021-01-06

Review 3.  Treatment of Giant Cell Arteritis (GCA).

Authors:  Alexis Régent; Luc Mouthon
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

4.  Serum C-Reactive Protein and Interleukin-6 Levels as Biomarkers for Disease Severity and Clinical Outcomes in Patients with Idiopathic Granulomatous Mastitis.

Authors:  Yi-Min Huang; Chiao Lo; Chiao-Feng Cheng; Cheng-Hsun Lu; Song-Chou Hsieh; Ko-Jen Li
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

Review 5.  Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.

Authors:  Andriko Palmowski; Frank Buttgereit
Journal:  Curr Rheumatol Rep       Date:  2020-10-12       Impact factor: 4.592

Review 6.  Advances in the Treatment of Giant Cell Arteritis.

Authors:  Santos Castañeda; Diana Prieto-Peña; Esther F Vicente-Rabaneda; Ana Triguero-Martínez; Emilia Roy-Vallejo; Belén Atienza-Mateo; Ricardo Blanco; Miguel A González-Gay
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.